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Early Enhanced Th1 Response after Leishmania amazonensis Infection of
C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to Resolution of
Infection
Abstract
C3H and C57BL/6 mice are resistant to Leishmania major but develop chronic lesions with persistent parasite
loads when they are infected with Leishmania amazonensis. These lesions develop in the absence of
interleukin-4 (IL-4), indicating that susceptibility to this parasite is not a result of development of a Th2
response. Expression of the cytokine IL-10 during infection could account for the lack of IL-12 expression
and poor cell-mediated immunity towards the parasite. Therefore, we tested the hypothesis that IL-10 plays a
central role in downmodulating the Th1 response after L. amazonensis infection. Infection of C57BL/6
IL-10-deficient mice indicated that in the absence of IL-10 there was early enhancement of a Th1 response,
which was downregulated during the more chronic stage of infection. In addition, although there were 1- to
2-log reductions in the parasite loads within the lesions, the parasites continued to persist, and they were
associated with chronic lesions whose size was similar to that of the control lesions. These experiments
indicated that L. amazonensisresistance to killing in vivo is only partially dependent on expression of host
IL-10. However, IL-10-deficient mice had an enhanced delayed-type hypersensitivity response during the
chronic phase of infection, indicating that there were Th1 type effector cells in vivo at this late stage of
infection. These results indicate that although IL-10 plays a role in limiting the Th1 response during the acute
infection phase, other immunomodulatory factors are responsible for limiting the Th1 response during the
chronic phase.
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Early Enhanced Th1 Response after Leishmania amazonensis Infection
of C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to
Resolution of Infection
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C3H and C57BL/6 mice are resistant to Leishmania major but develop chronic lesions with persistent
parasite loads when they are infected with Leishmania amazonensis. These lesions develop in the absence of
interleukin-4 (IL-4), indicating that susceptibility to this parasite is not a result of development of a Th2
response. Expression of the cytokine IL-10 during infection could account for the lack of IL-12 expression and
poor cell-mediated immunity towards the parasite. Therefore, we tested the hypothesis that IL-10 plays a
central role in downmodulating the Th1 response after L. amazonensis infection. Infection of C57BL/6
IL-10-deficient mice indicated that in the absence of IL-10 there was early enhancement of a Th1 response,
which was downregulated during the more chronic stage of infection. In addition, although there were 1- to
2-log reductions in the parasite loads within the lesions, the parasites continued to persist, and they were
associated with chronic lesions whose size was similar to that of the control lesions. These experiments
indicated that L. amazonensis resistance to killing in vivo is only partially dependent on expression of host
IL-10. However, IL-10-deficient mice had an enhanced delayed-type hypersensitivity response during the
chronic phase of infection, indicating that there were Th1 type effector cells in vivo at this late stage of infection.
These results indicate that although IL-10 plays a role in limiting the Th1 response during the acute infection
phase, other immunomodulatory factors are responsible for limiting the Th1 response during the chronic
phase.
Infection of mice with Leishmania spp. that cause cutaneous
leishmaniasis has led to an understanding of many of the im-
munological events that are required for a successful host
response towards these protozoan parasites. This experimental
system has helped define factors necessary for the generation
of the Th1 and Th2 types of immune responses in vivo (37, 42).
Many studies have demonstrated that the host responses to
different species or strains of Leishmania can vary in the same
mouse strain. For example, BALB/c mice develop a fatal Th2
response after Leishmania major infection and yet are resistant
to Leishmania braziliensis (9, 11). A more recent example is the
finding that interleukin-4 (IL-4)-knockout (KO) and IL-4 re-
ceptor-KO mice have different susceptibilities to infection with
different strains of L. major (27, 32, 33). Similarly, C3H and
C57BL/6 mice are resistant to L. major but develop chronic
lesions with persistent parasite loads when they are infected
with L. amazonensis (2, 5, 7, 39, 45). These studies demonstrate
that both host and parasite factors influence the outcome of an
infection.
Recent work has shown that the in vivo T-cell response
towards Leishmania amazonensis is different from that de-
scribed for other Leishmania species. The chronic lesions char-
acteristic of L. amazonensis infection in C57BL/6 and C57BL/10
mice are independent of expression of IL-4 and a correspond-
ing Th2 response (2, 23). In addition, L. amazonensis infection
in C3H mice results in low levels of production of IL-12 and
gamma interferon (IFN-) by antigen-specific CD4 T cells
(23). However, lesion development and parasite burden have
been shown to be exacerbated in the presence of CD4 T cells,
demonstrating that T cells are activated during L. amazonensis
infection and that they contribute significantly to the immuno-
pathology of the chronic disease (44). We have shown that
chronic infection by L. amazonensis in C3H and C57BL/6 mice
is persistent even after administration of exogenous IL-12 (23).
The inability of IL-12 to drive an effective cell-mediated im-
mune response during L. amazonensis infection suggests that
the parasite can evoke a potent immunomodulatory mecha-
nism to evade widespread parasite killing and promote a
chronic infection. The importance of understanding the factors
involved in maintenance of this chronic disease is highlighted
by the fact that chronic cutaneous leishmaniasis in humans is
often correlated with a poor T-cell-mediated immune response
(43) or a mixed T-cell response (35).
IL-10 has been shown to be a potent immunomodulatory
molecule (30). This cytokine has been shown to play a role in
limiting IFN- production in T cells via downregulation of
IL-12 production in both macrophages and dendritic cells and
in downregulating antigen-presenting cell function by decreas-
ing the expression of major histocompatibility complex class II
and regulating the responsiveness and/or expression of co-
stimulatory molecules in the antigen-presenting cell popula-
tion (10, 13, 14–16, 26, 29, 36). In addition, IL-10 has been
associated with decreased immune responses to cutaneous
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leishmaniasis in people (6, 40), and inhibition of IL-10 during
the recall response increases IFN- levels (40). However, anti-
IL-10 treatment did not alter the course of infection in L.
major-susceptible BALB/c mice or L. major-resistant C57BL/6
mice (8). Recent reports have suggested that the primary role
of IL-10 during Leishmania infection may be to limit macro-
phage activation since FcR-mediated uptake of immunoglob-
ulin-opsonized parasites by macrophages leads to IL-10-de-
pendent inhibition of parasite killing (24). These studies also
demonstrated that IL-10-deficient BALB/c mice infected with
tissue-derived L. major amastigotes had significantly smaller
lesions and fewer parasites associated with the lesions than
wild-type (WT) control mice (24). In support of these data, a
recent study demonstrated that mice deficient in either immu-
noglobulin production or FcR expression were resistant to L.
amazonensis infection, although the role of IL-10 in this infec-
tious disease model is unknown (25).
Since C57BL/6 mice infected with L. amazonensis develop
chronic lesions with a persistent parasite burden independent
of a Th2 response, we tested the hypothesis that IL-10 is
responsible for limiting the host immune response during such
an infection. At 4 weeks postinfection, the tissue parasite load
was decreased and there was an enhanced Th1 response in the
absence of IL-10. However, at a more chronic stage of infec-
tion, parasites persisted within the lesions and there was no
increase in the Th1 response in the draining lymph nodes
(LN). In addition, lower numbers of IFN--producing cells in
the draining LN and lower levels of Leishmania-specific im-
munoglobulin G2a (IgG2a) antibody in the IL-10-deficient
mice suggested that in vivo IFN- levels were not enhanced in
the IL-10-deficient mice compared to those of WT mice. In
contrast, the positive delayed-type hypersensitivity (DTH) re-
sponse at 15 weeks postinfection demonstrated that potential
Th1 immune effector cells were present in vivo. These results
indicate that IL-10 does limit parasiticidal activity in the host
but does not play a major role in determining the phenotype of
the Th response during L. amazonensis infection.
MATERIALS AND METHODS
Parasites. L. amazonensis parasites (MHOM/BR/00/LTB0016) were grown to
the stationary phase in Grace’s insect cell culture medium (Life Technologies,
Grand Island, N.Y.) supplemented with 20% heat-inactivated fetal bovine se-
rum, 2 mM glutamine, 100 U of penicillin per ml, and 100 g of streptomycin per
ml. Stationary-phase parasites were washed twice in phosphate-buffered saline
(PBS) before they were used for infection. Freeze-thawed leishmanial antigen
(FT-ag) was obtained from stationary-phase promastigotes that were washed
twice in PBS, resuspended in PBS, and subjected to three freeze-thaw cycles
consisting of 70 and 37°C. The protein concentration was determined by the
bicinchoninic acid assay, the final concentration was adjusted to 2 mg/ml, and
aliquots were stored at 70°C before use. The parasite burden was determined
by performing a limiting dilution analysis as previously described (2).
Mice. Female C57BL/6 and B6.129P2-Il10tm1Cgn mice were purchased from
Jackson Laboratory (Bar Harbor, Maine). The mice were maintained in a spe-
cific-pathogen-free facility. The Committee on Animal Care at Iowa State Uni-
versity approved all protocols involving animals. Each mouse was inoculated with
5 106 stationary-phase promastigotes in 50 l of PBS in a hind footpad. Lesion
size was monitored with a dial micrometer (L. S. Starrett Co., Athol, Mass.), and
the results were expressed as the difference between the footpad thickness for the
uninfected foot and the footpad thickness for the infected foot.
DTH response. At 15 weeks postinfection, the uninfected right hind foot of
each mouse was measured, and 20-g portions of FT-ag in 50 l of PBS were
injected into one-half of the infected mice; each of the other mice received an
injection consisting of 50 l of PBS in the subcutaneous tissue of the uninfected
hind foot. At 24 h after antigen injection the right hind foot of each mouse was
measured again. No increase in footpad thickness was detected at this time in the
PBS-challenged mice (data not shown).
Recall response and ELISPOT analyses. LN cells draining the infected feet
were obtained 4 and 15 weeks postinfection as indicated below. The cells were
disassociated with a Tenbrock tissue homogenizer and were resuspended in
complete tissue culture medium (Dulbecco’s minimal essential medium contain-
ing 4.5 mg of glucose/ml, 2 mM L-glutamine, 100 U of penicillin 6-potassium/ml,
100 mg of streptomycin/ml, 25 mM HEPES, and 50 M 2-mercaptoethanol) at
a density of 5  106 cells per ml in a final volume of 200 l in U-bottom or
flat-bottom 96-well plates. The cells were incubated in medium only (unstimu-
lated), or they were stimulated with 50 g of FT-ag per ml. Supernatants were
harvested after 72 h, and IFN- and IL-4 levels were determined by enzyme-
linked immunosorbent assays (ELISA); the sensitivity of both assays was 39
pg/ml. The numbers of IL-12p40- and IFN--producing cells were determined ex
vivo by using enzyme-linked immunospot (ELISPOT) assays with 4- and 12-h
incubations, respectively, as described previously (41). The ELISA and IFN-
and IL-12 ELISPOT assays were performed with commercially available anti-
bodies (BD Pharmingen, San Diego, Calif.).
IgG2a antibody titers. Leishmania-specific antibody contents were determined
by using an ELISA based on a previously described assay (46). Briefly, polysty-
rene microtiter plates (Becton Dickinson, Franklin Lakes, N.J.) were coated with
1.0 g of L. major FT-ag per ml or 1.0 g of L. amazonensis FT-ag per ml in PBS
(pH 9.4) overnight at 4°C. The plates were washed as described previously and
blocked with 5% nonfat dry milk (Carnation) in PBS–0.05% Tween 20 for 2 h at
37°C. Serum samples were then serially diluted with 0.05% Tween 20 in PBS
starting at a dilution of 1:100. The samples were incubated overnight at 4°C. The
plates were washed in PBS–0.05% Tween 20 five times, and bound antibodies
were detected with goat anti-mouse IgG2a directly conjugated to horseradish
peroxidase (Southern Biotechnology Associates, Birmingham, Ala.) and diluted
1:5,000 in PBS containing 25% normal goat serum (pH 9.4). After 2 h of
incubation at 37°C, the plates were washed with PBS–0.05% Tween 20, and the
2,2-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) peroxidase substrate
(Kirkegaard and Perry Laboratories, Gaithersburg, Md.) was then added. The
plates were read at A405 with a microplate reader (Molecular Devices, Sunnyvale,
Calif.). The antibody titer was expressed as the optical density at 405 nm of the
1:300 dilution. All sera from uninfected animals were negative, as determined by
optical densities at 405 nm of 1:300 dilutions (data not shown).
Immunohistochemistry. At different times after infection, tissue from each
mouse was fixed in 10% buffered formalin and routinely processed for paraffin-
imbedded sectioning, and then 8-m-thick sections were cut, applied to poly-L-
lysine-coated slides, and stained with hematoxylin and eosin. Additional un-
stained sections were used for immunohistochemical detection of inducible nitric
oxide synthase (iNOS) expression. Briefly, slides were incubated in a 1:10,000
dilution of a polyclonal rabbit IgG anti-mouse iNOS antibody (06-573; Upstate
Biotechnology Incorporated, Lake Placid, N.Y.) in primary dilution buffer (Op-
timax; BioGenex, San Ramon, Calif.). Control sections were incubated with
polyclonal rabbit IgG (12-370; Upstate Biotechnology). The primary antibody
was detected by using adsorbed affinity-purified biotinylated goat anti-rabbit
antibody (076-15-061; Kirkegaard and Perry) at a dilution of 1:200 in Optimax
primary diluent. Super-sensitive-streptavidin-conjugated peroxidase was used for
secondary antibody detection (BioGenex), and the signal was generated by using
Nova Red (Vector Laboratories, Burlingame, Calif.). Tissue sections were then
counterstained with Shandon’s hematoxylin. Control sections were negative, as
were footpad sections stained for iNOS from uninfected animals (data not
shown).
Statistical procedures. Statistical significance was determined by analysis of
variance by using StatView (SAS Institute Inc.). Differences between means were
considered significant if P was 0.05. Results are presented below as means 
standard errors, unless indicated otherwise.
RESULTS
L. amazonensis infection of IL-10-deficient mice. IL-10-defi-
cient and C57BL/6 WT mice were infected with 5  106 sta-
tionary-phase L. amazonensis parasites. Lesion size was mea-
sured over time. Figure 1A shows that IL-10-deficient mice
developed persistent lesions similar to those of the WT mice.
Parasite numbers associated with the lesions were determined
4 and 15 weeks postinfection. The results indicate that al-
though the lesion sizes were comparable in the two infections,
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there was a 1.1-log reduction in parasite load at 4 weeks postin-
fection and a 2.2-log reduction in parasite load at 15 weeks
postinfection in the IL-10-deficient mice (Fig. 1B).
Histology and iNOS expression in tissue. Hematoxylin- and
eosin-stained sections from both IL-10-deficient mice and WT
mice infected with L. amazonensis revealed similar lesion mor-
phologies at 4 weeks postinfection. L. amazonensis-infected
footpads in both IL-10-deficient mice and WT mice contained
dense infiltrates of inflammatory cells that extended from the
superficial dermis to the deep dermis. However, in the IL-10-
deficient mice, within the inflammatory infiltrate were multi-
focal areas of necrosis involving up to 20% of the section. In
the remaining areas there were dense infiltrates of macro-
phages, neutrophils, lymphocytes, and occasional plasma cells.
Admixed with these leukocytes were moderate numbers of
fibroblasts and fibrous connective tissue. Most macrophages
had abundant cytoplasm with one to several variably sized
vacuoles that were empty or contained one to several amasti-
gotes. The numbers of amastigotes in the footpads of the WT
mice were greater (Fig. 2A and C). An immunohistochemistry
analysis in which we used antibodies that detected iNOS indi-
cated that cells whose morphology was consistent with the
morphology of macrophages and which were present in the
lesions of both IL-10-deficient mice and WT mice upregulated
this enzyme after infection. However, at 4 weeks postinfection,
iNOS staining was more readily detectable and more intense in
the lesions of the IL-10-deficient mice than in the lesions of the
WT mice (Fig. 2B and D). Both iNOS-expressing cells and
parasites were readily detectable at 15 weeks postinfection in
WT and IL-10-deficient mice (data not shown).
Ex vivo detection of IL-12p40-producing LN cells. We have
previously shown that in C3H mice the level of IL-12-produc-
ing cells in the LN draining the site of L. amazonensis infection
remains near the level in uninfected mice. Since IL-10 has been
shown to inhibit IL-12, we analyzed IL-12 production ex vivo
by using the ELISPOT assay for IL-12p40-producing cells.
IL-10-deficient mice infected with L. amazonensis as described
above did have increased numbers of IL-12-producing cells in
their draining LN at 4 weeks postinfection compared to the
numbers of IL-12-producing cells in uninfected mice (Fig. 3A).
Consistent with data obtained with C3H mice, the numbers of
these cells in the WT mice were not greater than the numbers
in uninfected mice.
IFN- production. An analysis of the numbers of IFN--
producing cells in the draining LN at 4 weeks postinfection
demonstrated that the numbers of these cells were greater than
the numbers in uninfected animals in both the IL-10-deficient
mice and the WT mice. In contrast to the numbers of IL-12-
producing cells, there were fewer cells producing IFN- in the
IL-10-deficient mice than in the WT mice, although the back-
ground levels in uninfected animals were not statistically dif-
ferent (Fig. 3B). Therefore, the postinfection increase in the
numbers of IFN--producing cells compared to the levels in
uninfected animals was greater for the WT mice (8.11-fold
increase) than for the IL-10-deficient mice (6.88-fold increase).
Despite the lower numbers of IFN--producing cells de-
tected ex vivo in the draining LN, the antigen-specific recall
response at 4 weeks postinfection demonstrated that LN cells
from infected IL-10-deficient mice did have the potential to
produce more IFN- than LN cells from infected WT mice
could produce. However, at 15 weeks postinfection, when
there was still a persistent parasite load in the IL-10-deficient
mice, these mice did not have increased IFN- in the recall
response compared to the IFN- in the recall response in
infected WT mice. In addition, the levels of IFN- produced in
both groups of mice were less than the levels detected with the
recall response at 4 weeks postinfection (Fig. 4). At 4 weeks
postinfection IL-4 production was low in both the IL-10-defi-
cient mice and the WT mice (mean production, 74 80 and 73
 115.6 pg/ml, respectively). At 15 weeks postinfection there
was 39.2  97 pg of IL-4 per ml in the recall response of the
IL-10-deficient mice and no IL-4 was detected in the WT mice.
Leishmania-specific IgG2a production. Given the dichotomy
between the ELISPOT analysis results and the results of the
recall response analysis, we measured the relative levels of
Leishmania-specific IgG2a antibodies in order to assess in vivo
FIG. 1. IL-10-deficient mice have chronic lesions with detectable
parasites. (A) IL-10-deficient mice and WT controls were inoculated in
the left hind footpad with 5  106 stationary-phase L. amazonensis
promastigotes. Lesion size was monitored over time with a dial micro-
meter and was expressed as the difference between the footpad thick-
ness for the infected foot and the footpad thickness for the uninfected
foot. The results are representative of the results of three separate
experiments performed with five mice per group. The values are the
mean  standard deviation lesion sizes for WT mice () and IL-10-
deficient mice (). (B) Numbers of parasites in the infected feet at 4
and 15 weeks postinfection (see Materials and Methods). The stippled
bars and the solid bars represent data obtained with WT and IL-10-
deficient mice, respectively. The values are means  standard errors
based on three experiments performed with three to five mice per
group. P was 0.005 and 0.001 for the 4- and 15-week postinfection
values, respectively.
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IFN- production during the immune response. Figure 5 shows
that at 15 weeks after L. amazonensis infection there was a
significant decrease in the level of Leishmania-specific IgG2a
isotype antibodies in the IL-10-deficient mice compared to the
level in the WT control mice. These results are in agreement
with the ELISPOT assay results which indicated that lower levels
of IFN- were expressed in vivo in the IL-10-deficient mice.
DTH response. To further assess the phenotype of the in
vivo immune response, mice were tested for a DTH response
by using the uninfected footpads. Half of the mice received an
injection of antigen, and the other half received an injection of
PBS as a control. After 24 h measurements of the injected feet
were obtained, the mice were then sacrificed for the end point
analysis. At 24 h after antigen challenge, the IL-10-deficient
mice exhibited a significant increase in footpad thickness com-
pared to the footpad thickness of the antigen-challenged WT
mice (Fig. 6).
DISCUSSION
To determine the role of IL-10 in limiting cell-mediated
immunity during experimental L. amazonensis infection, we
used IL-10-deficient mice with a C57BL/6 background. L. ama-
zonensis infection of IL-10-deficient mice and WT mice re-
sulted in the development of chronic lesions over time and
readily detectable numbers of parasites associated with the
lesions (Fig. 1 and 2). The lesions in both the IL-10-deficient
mice and the controls contained parasites and a lymphocytic
infiltrate at the infection site 4 weeks postinfection (Fig. 2).
There were, however, increased areas of necrosis associated
with the infection in the IL-10-deficient mice (Fig. 2). These
results are consistent with reports that have described in-
creased necrosis of the liver after systemic infection of IL-10-
deficient mice with Trypanosoma cruzi, Schistosoma mansoni,
and Toxoplasma gondii (17, 22, 49). Peroral infection of IL-10-
deficient mice with T. gondii resulted in necrosis of substantial
areas of the intestinal epithelium (48). The role that necrosis
plays in limiting parasite persistence during Leishmania infec-
tion is unknown, but it is possible that increased necrosis of
infected tissue could contribute to increased parasiticidal ac-
tivity in the IL-10-deficient mice. Regardless of the increases in
tissue necrosis, our study indicates that IL-10 expression does
not influence the resolution of the chronic lesions that are
FIG. 2. L. amazonensis-infected IL-10-deficient mice have decreased parasite numbers and increased iNOS expression in vivo compared to WT
mice. WT and IL-10-deficient mice were infected with L. amazonensis as described in the legend to Fig. 1, and the infected footpad of each mouse
was harvested 4 weeks postinfection. (A) Histology of an L. amazonensis-infected footpad of a WT mouse. The arrows indicate parasites within
macrophages. (B) Tissue section of an L. amazonensis-infected footpad of a WT mouse stained for iNOS (brown). (C) Histology of an L.
amazonensis-infected footpad of an IL-10-deficient mouse. The arrow indicates parasites, and an area of necrosis is outlined. (D) Tissue section
of an L. amazonensis-infected footpad of an IL-10-deficient mouse stained for iNOS (brown). The tissue sections are representative of tissue
sections of footpads harvested from two individual WT or IL-10-deficient mice from three separate experiments. The tissue sections were processed
for hematoxylin and eosin staining and iNOS expression as described in Materials and Methods. Magnification, 20.
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characteristic of L. amazonensis infection in these mice. How-
ever, IL-10 does promote parasite survival, since in the absence
of IL-10 1- to 2-log reductions in parasite load were detected at
both 4 and 15 weeks postinfection (Fig. 1B). The reduced
parasite load is similar to that reported for IL-10-deficient
mice with a BALB/c background when they were infected with
L. major. However, the lesions in the BALB/c mice were re-
duced compared to those in the control mice (24). The differ-
ence in these results is that after L. major infection, BALB/c
mice develop progressive lesions with a concomitant Th2 re-
sponse, whereas L. amazonensis infection in C57BL/6 mice
results in chronic lesions in the absence of a Th2 response.
In our analysis of the IL-10-deficient mice after L. ama-
zonensis infection, we detected an increase in the amount of
IFN- in the recall response of the draining LN at 4 weeks
after infection (Fig. 4). Although we did not determine the
source of IFN-, the increase did correlate with a small but
significant increase in the number of IL-12-producing cells in
the draining LN and an enhanced DTH response. These re-
sults are consistent with an increase in a T-cell-mediated re-
sponse and suggest that there is some biological significance to
the increase in IL-12. The modest increase in the Th1 response
after L. amazonensis infection is in contrast to the immune
response of IL-10-deficient mice infected with T. gondii or T.
cruzi. Systemic infections with these protozoans caused an im-
mune hyperactivity that resulted in a lethal immune response
FIG. 3. IL-10-deficient mice have increased numbers of IL-12p40-
producing cells and decreased numbers of IFN--producing cells at 4
weeks postinfection. (A) IL-10-deficient (IL-10 KO) and WT mice
were infected as described in the legend to Fig. 1. At 4 weeks postin-
fection the numbers of IL-12p40-producing cells in the draining LN
were determined by an ELISPOT assay (see Materials and Methods).
P was 0.04 for the infected IL-10-deficient mice compared to unin-
fected IL-10-deficient mice. (B) Numbers of IFN--producing cells, as
determined by an ELISPOT assay, from the same mice as described
above for panel A. P was 0.001 for the infected IL-10-deficient mice
compared to the infected WT mice. The stippled bars and the solid
bars represent data for uninfected and infected mice, respectively. PC,
producing cells. The values are means  standard errors based on
three separate experiments performed with three to five animals per
group.
FIG. 4. Increased IFN- production from the recall response at 4
weeks postinfection but not at 15 weeks postinfection in L. amazonen-
sis-infected IL-10-deficient mice. IL-10-deficient and WT mice were
infected as described in the legend to Fig. 1. At the times indicated a
3-day antigen-specific recall response analysis was performed by using
LN cells draining the site of infection. The levels of IFN- in the
supernatants were determined by ELISA. The stippled bars and the
solid bars represent data for WT and IL-10-deficient mice, respec-
tively. The values are means standard errors based on three separate
experiments performed with five mice per group. P was 0.0085 for the
IL-10-deficient mice compared to the WT mice at 4 weeks postinfec-
tion.
FIG. 5. L. amazonensis-specific IgG2a antibody levels are signifi-
cantly decreased in IL-10-deficient mice. At 15 weeks postinfection
serum was collected from IL-10-deficient mice (IL-10 KO) and WT
mice, and the relative levels of Leishmania-specific IgG2a antibodies
were determined as described in Materials and Methods. The values
are means  standard errors based on three separate experiments
performed with five to seven animals per group. P 	 0.027. O.D. 405,
optical density at 405 nm.
FIG. 6. IL-10-deficient mice have an increased DTH response. At
15 weeks postinfection IL-10-deficient mice (IL-10 KO) and WT mice
were each challenged with 20 g of FT-ag in the uninfected footpad.
Swelling was measured 24 h after the challenge. The values are means
 standard errors based on three separate experiments performed
with three or four animals per group challenged with antigen (see
Materials and Methods). P  0.001.
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mediated by IFN- from CD4 T cells (17, 22, 31). In addition,
in our experiments, the ratio of IFN--producing cells in the
LN of infected mice to IFN--producing cells in the LN of
uninfected mice was not greater for the IL-10-deficient mice
than for the WT mice (Fig. 3B). In fact, the decrease in the
number of IFN--producing cells in the L. amazonensis-in-
fected IL-10-deficient mice suggests that in the absence of
IL-10, significant immunomodulatory mechanisms that limit
IFN- production in vivo are upregulated. This conclusion is
supported by the fact that the titers of IFN--dependent Leish-
mania-specific IgG2a isotype antibodies were lower in the IL-
10-deficient mice than in the WT mice (Fig. 5). Together, the
data clearly indicate that any enhancement of the Th1 re-
sponse due to the absence of host IL-10 is insufficient for an
effective cell-mediated immune response to L. amazonensis
and resolution of the infection.
There have been several studies demonstrating the associa-
tion of IL-10 production with leishmanial infection in human
and experimental murine infections. In these studies neutral-
ization of IL-10 during in vitro analysis indicated that IL-10
plays a role in limiting IFN- production from CD4 T cells
and NK cells during Leishmania infection (40, 41). However,
recent studies have demonstrated that during cutaneous leish-
maniasis, IL-10 promotes parasite survival by influencing mac-
rophage activation and that the role of IL-10 in determining
the phenotype of the T-cell response is less important (18, 19,
24). In our studies, the observation that there is a low level of
in vivo IFN- production but a high level of iNOS expression
(Fig. 2D) with a decreased parasite load is consistent with the
hypothesis that IL-10 plays a primary role in limiting macro-
phage activation during cutaneous leishmaniasis. The iNOS
expression detected at 15 weeks postinfection (data not shown)
suggests that there is persistent macrophage activation during
later stages of the disease. These results are consistent with
previous studies demonstrating the importance of NO in lim-
iting parasite numbers in mice chronically infected with L.
major (47). However, the persistence of L. amazonensis para-
sites in the IL-10-deficient mice indicates that the presence of
these parasites during chronic infection is only partially depen-
dent on expression of host IL-10.
After 15 weeks, localized footpad infection by L. amazonen-
sis becomes relatively quiescent, and there is no increase in
IL-12-producing cells in the draining LN, even in the presence
of readily detectable parasites (data not shown). In addition,
there is no detectable increase in the antigen-specific Th1
response in the draining LN of IL-10-deficient mice at this time
(Fig. 4). Given the absence of a sustained increase in these
parameters for the Th1 type of immunity in the draining LN,
these results suggest that regulation of the Th1 response is
independent of IL-10. These results are similar to those de-
scribed for infection of IL-10-deficient mice with S. mansoni,
which resulted in an increase in Th1 cytokines and a mixed
Th1/Th2 immune phenotype during the acute immune re-
sponse. As the disease progressed to a chronic stage, there was
downregulation of Th1-associated cytokines. This regulation of
the enhanced Th1 response was subsequently shown to be
dependent on endogenous IL-4 (20, 49). Previous work with L.
amazonensis has demonstrated that IL-4 does not play a role in
limiting the immune response during this infection (2, 23). In
agreement with the previous studies, very little IL-4 was de-
tected in the recall responses of L. amazonensis-infected mice,
whether they were IL-10-deficient mice or control mice. There-
fore, we believe that downregulation of the Th1 response in L.
amazonensis-infected IL-10-deficient mice is independent of
IL-4.
The enhanced DTH response of L. amazonensis-infected
IL-10-deficient mice does demonstrate that Th1 effector cells
are present in vivo (Fig. 6). Previous studies have shown that
IL-10 can inhibit the DTH response, at least in part, by limiting
vascular permeability and swelling during the DTH response
(28). Increases in these parameters of footpad swelling in IL-
10-deficient mice during infection could account for the finding
that the lesion size was equivalent to that in WT mice, even
though the parasite load in the tissue was 1 to 2 logs lower in
the IL-10-deficient mice. The dichotomy between the en-
hanced DTH response and the low IFN- levels detected in the
recall response of the draining LN could be reconciled if the
antigen interaction with the antigen-presenting cell–T-cell
stimulation pathway in vivo was limited. This scenario could
suggest that there are more antigen-specific memory T cells in
the peripheral tissue and fewer antigen-specific Th1 effector,
IFN--producing cells in the draining LN. An increase in the
peripheral activated memory cells has been described previ-
ously for IL-10-deficient mice, and it has recently been shown
that few Th1 effector cells occur in secondary lymphoid organs
in mice after an antigen challenge (3, 38). Regulation of anti-
gen presentation in vivo would be consistent with in vitro data
for the same organism that demonstrated that this parasite has
several methods that prevent antigen stimulation of T cells (1,
4, 12, 34). Alternatively, increased iNOS expression is a possi-
ble mechanism of Th1 suppression through increased nitric
oxide levels. This could account for local regulation of the
immune response at the draining LN and is consistent with the
role of nitric oxide in limiting T-cell responses during other
intracellular protozoan infections, including infections of IL-
10-deficient mice with Toxoplasma and infections of C57BL/6
mice with L. major (21, 31). Work is under way to determine
what IL-10-independent mechanisms regulate the IL-12-pro-
ducing cells and the Th1 cells that are detected in the recall
response at 4 weeks postinfection and in the DTH response at
15 weeks postinfection.
In conclusion, the data presented here demonstrate that in
the mouse model of cutaneous leishmaniasis, susceptibility to
L. amazonensis is dependent not only on expression of IL-10.
L. amazonensis parasites persist in IL-10-deficient mice, even
in the presence of an enhanced Th1 response during the early
stages of infection and in the presence of antigen-specific cells
primed for Th1 effector function during the chronic phase.
These persistent parasites are associated with chronic nonheal-
ing lesions. Our results are consistent with a model proposing
that IL-10 expression during Leishmania infection is important
more for determining the level of macrophage activation and
subsequent leishmanicidal activity than for influencing the T-
cell response. Our results also demonstrate that L. amazonen-
sis can evoke IL-10-independent mechanisms to limit in vivo
IFN- production. Understanding these mechanisms at the
systemic and cellular levels is necessary for us to propose
adequate immunomodulatory strategies for preventive or cur-
ative procedures.
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